key: cord-0998027-pukl3vhs
authors: Payen, D.; Cravat, M.; Maadadi, H.; Didelot, C.; Prosic, L.; Dupuis, C.; Losser, M.-R.; De Carvalho Bittencourt, M.
title: A longitudinal study of immune cells in severe COVID-19 patients.
date: 2020-06-19
journal: nan
DOI: 10.1101/2020.06.16.20130914
sha: 752ef63234307a3ee83a565cedd1752c7fe0d5f5
doc_id: 998027
cord_uid: pukl3vhs

Little is known about the time-dependent immune responses in severe COVID-19. Data of 15 consecutive patients were sequentially recorded from intensive care unit admission. Lymphocyte subsets and total monocyte and subsets counts were monitored as well as the expression of HLA-DR. For 5 patients, SARS-CoV-2-specific T-cell polyfunctionality was assessed against Spike and Nucleoprotein SARS-CoV-2 peptides. Non-specific inflammation markers were increased in all patients. Median monocyte HLA-DR expression was below the 8,000 AB/C threshold defining acquired immunodepression. A V trend curve for lymphopenia, monocyte numbers, and HLA-DR expression was observed with a nadir between days 11-14 after the onset of symptoms. Intermediate CD14++CD16+ monocytes increased early with a reduction in classic CD14++CD16- monocytes. Polyfunctional SARS-Cov-2-specific CD4 T-cells were present and functional, whereas virus-specific CD8 T-cells were less frequent and not efficient. We report a temporal variation of both innate and adaptive immunity in severe COVID-19 patients, helpful in guiding therapeutic decisions (e.g. anti-inflammatory vs. immunostimulatory ones). We describe a defect in virus-specific CD8 T-cells, a potential biomarker of clinical severity. These combined data also provide helpful knowledge for vaccine design.

The SARS-CoV-2 outbreak causes a spectrum of clinical patterns that vary from asymptomatic but potentially contagious infection to mildly symptomatic and severe forms (Zhou et al., 2020) .

The latter brings the patient to Intensive Care Units (ICU) for mechanical ventilation (Phua et al., 2020) . Currently, little is known about clinical patterns and immune response relationships.

Significant modifications reported in severe forms of COVID-19 include elevated nonspecific plasma markers (C-reactive Protein [CRP] , ferritin, lactate dehydrogenase [LDH]) associated with marked lymphopenia, mainly of CD4 and CD8 T-cell subsets (Chen et al., 2020b; Li et al., 2020) . The latter, associated with decrease in HLA-DR expression on monocytes (Giamarellos-Bourboulis et al., 2020) , suggest acquired immune-suppression, as observed in bacterial sepsis (Lukaszewicz et al., 2009) . Elevated levels of pro-inflammatory cytokines, mainly IL-6, have led to the hypothesis of an innate-mediated "cytokine storm" driving neutrophilia and defective antigen-presentation (Giamarellos-Bourboulis et al., 2020) . These dysregulations of both innate and adaptive immunity (Vardhana and Wolchok, 2020) explain apparent contradictions in COVID-19 therapeutic trials (Ingraham et al., 2020) . A better understanding of the longitudinal evolution of innate and adaptive immune responses during severe COVID-19 disease is needed before decisions on immune-modulation and clinically relevant immune-monitoring (Payen, 2020) .

This prospective study of ICU COVID patients reports a monocentric longitudinal evaluation of innate immunity based on monocyte subsets expression of HLA-DR (Vardhana and Wolchok, after d24. Similar analyses were performed referring to the delay from ICU admission: A: d0-4; B: d5-8; C: d9-12; D: late > d12 (Table S2) .

Routine parameters, nonspecific inflammatory markers and immune-cells characterization were first measured on ICU admission (Tables 1 and 2) and these values considered as baseline. Serial measurements were repeated until the patient was discharged or died. Flow-cytometry wholeblood routine analyses of circulating monocytes and lymphocytes were performed at the Diagnostic Flow-Cytometry platform of CHRU Nancy by using the BD FACSLyric™ Clinical System (BD Biosciences, San Jose, CA). All fluorochrome-conjugated antibodies and reagents were from BD Biosciences. Relative and absolute populations sizes were determined and HLA-DR expression was quantified as number per cell (antibodies bound per cell [AB/C] arbitrary units) using a commercial kit (Quantibrite™, BD Biosciences). Total monocytes HLA-DR median expression in healthy donors, using similar set-up conditions, was 16,884 (5,842-29, 175 ) AB/C. Our laboratory's threshold for acquired immunodepression diagnosis is 8,000 AB/C (Gouel-Cheron et al., 2015; Payen et al., 2019) . "Normal proportions" for monocyte subsets are 80-95% for classical monocytes, 2-8% for non-classical monocytes and 2-11% for intermediate monocytes (Sampath et al., 2018; Ziegler-Heitbrock, 2015) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020 . . https://doi.org/10.1101 /2020 Adaptive immunity: Routine whole-blood immunophenotyping of T, B and NK lymphocytes by flow-cytometry determined relative and AN of lymphocytes and their subsets, i.e. CD3 + T-cells, CD3 + CD4 + T-cells, CD3 + CD8 + T-cells, CD19 + B-cells, CD3 -CD16 + 56 + NK-cells. Regulatory Tcells (Treg) were identified in whole blood as CD3 + CD4 + CD25 ++ CD127 neg/low cells (Liu et al., 2006; Seddiki et al., 2006) . SARS-CoV-2-specific T-cell polyfunctionality (Boyd et al., 2015; Seder et al., 2008) against viral peptides was assessed in 5 patients to further explore COVID-19 adaptive immunity (patients #7, #9, #11, #12 and #13). Patients' PBMC from 19 to 29 days after the onset of symptoms were stimulated ex-vivo by overlapping peptides covering protein sequences of the Spike and Nucleoprotein SARS-CoV-2 antigens (JPT Peptide Technologies, Berlin, Germany). Antigen-specific T-cells reactivity was assessed by intracellular IFN- TNF- and IL-2 production (Lamoreaux et al., 2012) . Navios ® flow-cytometer and Kaluza ® software v2.1 (Beckman Coulter, Miami, FL) were used for data acquisition and analysis. As positive controls, PBMC were also stimulated by a mix of immunodominant microbial peptides (CEFX peptide pool; JPT Peptide Technologies) for diverse microbial antigens-specific TH1 responses.

Antigen-specific CD4 and CD8 T-cells polyfunctionality was expressed by using the "Polyfunctionality Index" (PI) (Boyd et al., 2015; Larsen et al., 2012a) . More details in reagents, flow-cytometry gating strategy used for the selection and quantification of Sars-Cov-2-specific-T-cells are shown in Table S3 and Figure S3 .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 19, 2020 . . https://doi.org/10.1101 /2020 STATISTICAL ANALYSES Data are described as number (%) and median (interquartile range (IQR)) for categorical and continuous variables respectively. Comparisons relied on Fisher exact test for categorical data;

Kruskal-Wallis or Wilcoxon tests were used for continuous data and Wilcoxon test for paired data test whenever necessary. An ANCOVA test for repeated measurements was used for comparison of the different types of HLA-DR. A p-value of less than 0.05 was considered statistically significant. All analyses were performed using SAS software, version 9.4 (SAS Institute Inc., Cary, NC).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 19, 2020 . . https://doi.org/10.1101 /2020 

Fifteen severe COVID-19 ICU patients, median age 66 years old [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] , 80% male, were investigated ( Table 1) . Because of hypoxia deterioration, all except 1 (Table S1 ) needed intubation and mechanical ventilation with a protective lung protocol. Importantly, none of the patients received any direct or indirect antiviral drugs nor specific immunomodulating drugs.

Only 3 patients received low dose of prednisolone during their ICU stay (Table 1) . Comorbidities were present in 47% of the patients (Table 1) . Hypertension (46.7%) and obesity (40%) were the most frequent, followed by pre-existent cancer (33.3%) and diabetes (26.7%) ( g/L) levels were also largely above normal ranges, a lipid abnormality never reported in severe septic patients (Biller et al., 2014) . AN and relative values of leukocyte subsets are shown in . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 19, 2020 . . https://doi.org/10.1101 /2020 Figure 1 . Considering the delay stratification from symptoms onset, there was globally no significant change in leukocyte AN (p= 0.09). Polymorphonuclears (PMN) initial AN were lower than the median observed at periods "D" (p = 0.04) and "E" (p = 0.06) ( Table 2 and Figure 1). A difference in monocyte AN was only significant when phase B (d11-14) was compared to the late phase E (p = 0.04) (Table 2 and Figure 1) . Importantly, the relative AN for the 3 major subtypes of monocytes did not change over time: CD16 + -intermediate cells proportions at ICU admission were largely above the admitted proportions (Ozanska et al., 2020; Wong et al., 2012) , with a concomitant reduction in the CD16cell subset. The ability of monocytes to express HLA-DR was lower than the threshold for acquired immunosuppression diagnosis at all periods, except the latest one (>24 days after initial symptoms) ( Figure 2 ). The lowest level of immunosuppression was observed at phase B and tended to recover during the ICU stay (p = 0.08) (Figure 2 ). Similar patterns were observed for all monocyte subtypes, albeit more pronounced for CD16 + ones (non-classical and intermediate). A significant positive correlation was found at all periods between HLA-DR expression and T-cells AN for CD4 (R 2 = 0.28; p <0.01) and CD8 T-cells (R 2 =0.22; p < 0.01) (not shown). Also, significant linear positive correlations were seen between HLA-DR expression on intermediate and non-classic monocyte subsets and CD4 T-cells AN (p <0.01) and between CD16 + intermediate subset and CD8 T-cells AN (p<0.01) (not shown). Considering alive of dead patients as those above or below the median SAPS2, no differences were observed for monocyte subsets proportions.

As reported (Chen et al., 2020a), global lymphocyte counts showed a severe reduction in AN compared to normal ranges (Table 2 and Figure 1 ). Lymphocyte AN changed significantly over time (p = 0.03). CD4 ("B" vs "D": p = 0.03) and CD8 ("B" vs "D": p = 0.02) T-cell AN were reduced at period B, being the "nadir" of lymphopenia, and then followed by a slow CD4 and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020 . . https://doi.org/10.1101 /2020 CD8 T-cells increase (p<0.03) (Figure 1 ). The CD4/CD8 ratio was not impacted by lymphopenia.

B-cells, NK-cells, and Treg numbers were stable along the monitoring time ( Table 2 ). The leukocyte moderate elevation associated with the total lymphocytes rapid decline resulted in a significant rise in PMNs/Lymphocytes ratio at the "nadir" period B, with subsequent normalization (Table 2) .

Peripheral SARS-CoV-2-specific T-cells were identified in 5 patients by using an intracellular staining assay and flow-cytometry to evaluate the production of 3 TH1 cytokines contributive to viral clearance (Seder et al., 2008) . PBMC were stimulated by 3 SARS-CoV-2 peptide pools (Sk1 and Sk2 pools and Nucleoprotein (NC pool)). The polyfunctionality Index (PI) for IFN-γ, TNF-α and IL-2 production showed that virus-specific CD4 T-cells were more polyfunctional than CD8 T-cells ( Figure 3 ). Remarkably, a high proportion of bi-functional and tri-functional CD4 T-cells was observed, whereas CD8 T-cells were essentially monofunctional ( Figure 3 ). Nucleoproteinspecific CD4 T-cells were less numerous than those specific for the Spike glycoprotein (both Sk1 and Sk2 pools), similarly to reported results (Weiskopf et al., 2020) . CD4 T-cells responses to immunodominant peptides from different infectious agents (CEFX pool) were much lower than CD8 T-cells responses (Figure 4 ).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . https://doi.org/10.1101/2020.06.16.20130914 doi: medRxiv preprint

The most significant predictors of disease severity in COVID-19 infection relate to both innate and adaptive immunity and their inter-relations. Until now, to our knowledge, no longitudinal clinical study on ICU-admitted patients has reported the evolution of monocyte subsets with concomitant HLA-DR expression and lymphocytes subsets AN. Precise knowledge of symptoms' onset allowed us to interpret the collected data as related to disease progression. Between symptoms' onset and ICU admission to ICU discharge or death, we observed a "V" curve trend for monocytes and their HLA-DR expression as well as for lymphopenia, with a nadir between days 11 to 14. This 2 weeks timing already reported as a risk period for clinical events (Zhou et al., 2020) was characterized by the lowest HLA-DR expression on monocyte subsets associated with the deepest CD4 and CD8 T-cells lymphopenia. We found that mainly polyfunctional SARS-Cov-2-specific CD4 T-cells were present 3 weeks after the onset of symptoms, while peripheral SARS-Cov-2-specific CD8 T-cells were less numerous and not efficient. However, a normal CD8 T-cells response for other microbial antigens was present, excluding a global functional defect of peripheral CD8 T-cells.

This ICU cohort had a predominance of males with high Body Mass Index and frequent comorbidities, as previously reported (Guan et al., 2020) . Acute respiratory syndrome with severe hypoxia imposed intubation and mechanical ventilation for 14/15 patients. However, our cohort differs from others by several aspects: no patient received any anti-viral therapy before and during ICU stay, avoiding a potential incidence on the immune profile. Moreover, no patient received specific immunomodulation therapy. At referral to ICU, all patients had elevated levels of non-specific markers of systemic inflammation such as ferritin, LDH, and CRP. The mortality rate (20%) was relatively low and none of the patients experienced shock nor multiorgan failure.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . https://doi.org/10. 1101 /2020 The reasons for that are not clear, except the reduced interference between drugs and immune status.

In absence of a longitudinal assessment, one point checking for immune status has big limitations. As shown here, both innate and adaptive immunity vary over time after SARS-CoV-2 infection. COVID-19 severity is related to an initial excessive inflammatory response, pro- patients (Zhang et al., 2020) . In our study, monocyte AN did not change along with COVID evolution in ICU, except when comparing the last measurements (>24 days) with those of days 11-14 after symptoms onset. Previous reports also showed maintained monocyte numbers (Merad and Martin, 2020). Proportions of the 3 monocyte subsets did not change significantly during the evolution period we studied. However, the intermediate CD14 ++ CD16 + subset was remarkably always above reported normal values (Ozanska et al., 2020; Wong et al., 2012) , which was . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. control, yet maintaining in increased pool of pathogen-specific memory T-cells (Cox et al., 2013; Swain et al., 2012) . More than the quantity itself, anti-viral "T-cells quality" is widely recognized as the most important for successful anti-viral responses. It relates to the cells' capacity to perform simultaneous anti-viral functions (e.g. cytokine or chemokine production, cytotoxicity, proliferation) (Boyd et al., 2015; Seder et al., 2008) . Indeed, polyfunctional and monofunctional T-cells differ at molecular levels (Burel et al., 2017) . At the time of writing, only 4 publications . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . https://doi.org/10. 1101 /2020 have assessed SARS-CoV-2-specific T-cells. Ni et al described them in COVID-19 recovered patients, using only IFN-γ ELISpot, possibly underestimating the magnitude and breadth of the response and not discriminating CD4 or CD8 virus-specific T-cells (Ni et al., 2020) . The other 3 studies identified by flow-cytometry T-cells upregulating activation markers (Braun et al., 2020; Grifoni et al., 2020; Weiskopf et al., 2020) . Although this "global activation" approach can potentially detect all antigen-specific T-cells, polyfunctional CD4 T-cells were not investigated. (Boyd et al., 2015; Larsen et al., 2012a) . Its application here showed that polyfunctional CD4 T-cells were present for at least one of the SARS-CoV-2 tested antigens in all 5 tested patients. Conversely, CD8 polyfunctional T-cells were not identified for any SARS-CoV-2 antigen in any patient. SARS-CoV-specific CD4 T-cells were mainly bi-(mostly TNF-α+IL-2+) and tri-functional (plus IFN-γ). Conversely, when present, the rare SARS-CoV-2specific CD8 -reactive T-cells were mainly monofunctional (producing either IFN-γ or TNF-α).

Of note, the CD8 T-cells reactive to the control mix of microbial peptides mentioned above (CEFX pool) were perfectly polyfunctional, indicating again that only the pool of peripheral SARS-CoV-2-specific CD8 T-cells is affected (Figures 3 and 4) . This difference in quantity and quality between CD4 and CD8 SARS-CoV-2-specific T-cells might be explained by a . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . https://doi.org/10.1101/2020.06.16.20130914 doi: medRxiv preprint preferential homing of the virus-specific effector CD8 T-cells to tissues, and especially the lungs and/or by T-cell functional exhaustion (Diao et al., 2020; Wherry and Kurachi, 2015) . The latter hypothesis, that would imply selective PD-1 expression, is not supported by the good specific In conclusion, we report the first concomitant and longitudinal evaluation of innate and adaptive immunity in COVID-19 severe cases. We believe that such extensive immunomonitoring studies are needed in order to accumulate a better knowledge in SARS-CoV-2 innate and adaptive immune-responses relationships. This approach might be helpful in making therapeutic decisions (e.g. anti-inflammatory vs. immunostimulation interventions) depending on the stage of the disease. This also will be of utmost importance for vaccine efficacy evaluation in future clinical trials.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. Convalescent Individuals. Immunity.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . https://doi.org/10.1101/2020.06.16.20130914 doi: medRxiv preprint related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome. medRxiv, 2020.2003.2024.20042655. Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020 . . https://doi.org/10.1101 /2020 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020 . . https://doi.org/10.1101 /2020 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . https://doi.org/10.1101/2020.06.16.20130914 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . https://doi.org/10.1101/2020.06.16.20130914 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . https://doi.org/10.1101/2020.06.16.20130914 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020 . . https://doi.org/10.1101 /2020 Supplement.

Peripheral blood was obtained by venipuncture and collected in heparin-containing tubes (BD Biosciences). Mononuclear cells (PBMC) were separated by density gradient no later than 6 hours after venipuncture, washed and counted prior to cell culture. PBMC (5x10 5 to 1.5x10 6 cells) were resuspended in 200µL of serum-free AIM-V medium and were separately stimulated overnight (12-14 hours) in 96 wells plate with peptide pools of overlapping 15-mer peptides (11 amino acid overlaps) spanning the entire Spike (divided in two pools of peptides: "SK1 and SK2") and Nucleoprotein (pool "NC") SARS-CoV-2 proteins (1.25 µg/mL of each peptide).

Brefeldin A (Sigma-Aldrich) was added to each well and the plates set at 37°C, 5% CO 2 humidified atmosphere. Unstimulated PBMCs (medium +DMSO, vehicle of the peptide pools) were used as negative controls. For positive controls of detecting antigen-specific responses, PBMC were separately stimulated with a control pool of 176 known immunodominant peptide epitopes of diverse infectious agents (CEFX pool). All peptide pools were from JPT Peptides (Berlin, Germany). All samples were also co-stimulated with antibodies directed against CD28 and CD49d (1 µg/mL, BD Biosciences). As positive controls of global TH1-immunocompetence, PBMC were also stimulated in parallel with Phorbol-Myristate-Acetate (50 ng/mL, Sigma-Aldrich) and Ionomycin (500 ng/mL, Sigma-Aldrich). After stimulation, cells were collected and washed before an incubation with BD Horizon™ Fixable Viability Stain 510 (FVS 510) and a cell surface antibody mix of anti-CD3 BB515, anti-CD4 PE-Cy7 and anti-CD8 PE-CF594. Cells were then fixed, washed and permeabilized according to the manufacturer's instructions by using IntraStain® kit (Dako). Next, the cells were incubated with an intracellular antibody mix of anti-IL2 PE, anti-TNF-α APC and anti-IFN-γ BV421. All conjugated antibodies were from BD . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020 . . https://doi.org/10.1101 /2020 Biosciences. After 2 washes, cells were resuspended in PBS and immediately proceeded to flow cytometry data acquisition. Data were acquired using a Navios® Flow Cytometer (Beckman Coulter). SARS-CoV-2 -specific T-cells were identified using Kaluza® software v2.1 (Beckman Coulter) as by a specific gating strategy (Suppl. Figure3). The same gating strategy was used for SARS-CoV-2 Ag-stimulated cells and the percentage of Ag-specific CD4 or CD8 T cells was determined after subtracting the percentage of cytokine-positive events in unstimulated controls.

Responses above the level of difference of 0.01% cytokine-producing cells were considered as Ag-specific positives (PMID: 19266489) . In order to quantify the polyfunctionality of SARS-CoV-2 specific T-cells, we calculated the Special Polyfunctionality Index (PI) for each stimulation condition and for CD4 and CD8 T cells as described (Larsen et al., 2012b) . We have used a higher ponderation for increasing polyfonctionnality (q=1.2) as determined in a series of statistical analysis correlating T-cell polyfunctionality and efficacy (Boyd et al., 2015) . Negative controls stimulation (medium plus co-stimulatory antibodies) present a background production of cytokines (mostly monofunctional cells), we then subtracted the Polyfunctional Index of negative controls from each specific antigenic stimulation in order to correct for this "background polyfunctionality" for each patient tested. The limit of detection for an augmentation of polyfunctionality was determined at 3 SD of results from 30 measures of negative controls for CD4 and CD8 of different subjects.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020 . . https://doi.org/10.1101 /2020 antigens was performed between d16 to d29. hrs: hours.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020 June 19, . . https://doi.org/10.1101 June 19, /2020 doi: medRxiv preprint Figure S2 . Flow-cytometry sequential gating strategy for identification of circulating monocytes subsets. Figure S2 legend: Singlets were first identified on a FSC-A vs. FSC-H dot plot (Plot A). Cells were next visualized on FSC vs. SSC plot and an ample "Monocytes Cloud" gate was set, excluding most neutrophils and lymphocytes (Plot B). These cells were then viewed on a CD14 vs. CD16 plot and a gate was drawn excluding CD14 negative and CD16 low/negative cells (gate "CD14 and/or CD16 pos", Plot C). Selected cells were next viewed on a CD16 vs. HLA-DR plot and the contaminating cells (''Not Monos'' gate) were easily distinguished from the ''true'' monocytes ("True Monos" gate, Plot D). These latter ''cleaned'' monocyte population was next viewed again on a CD14 vs. CD16 plot and gated as CD14++CD16-"Classical", CD14++CD16+ . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . https://doi.org/10.1101/2020.06.16.20130914 doi: medRxiv preprint Figure S3 . Flow-cytometry assessment of SARS-CoV-2 specific T-cells.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. . https://doi.org/10. 1101 /2020 Table S1 : Note the precise delay between the onset of symptoms and the ICU admission and intubation. ICU: intensive care unit; LOS: length of stay; MV: mechanical ventilation.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 19, 2020. All from BD Biosciences, except CD3 -APC, from Biolegend.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 19, 2020. . https://doi.org/10.1101/2020.06.16.20130914 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 19, 2020 . . https://doi.org/10.1101 /2020 

Cholesterol rather than procalcitonin or C-reactive protein predicts mortality in patients with infection

Pathogen-Specific T Cell Polyfunctionality Is a Correlate of T Cell Efficacy and Immune Protection

Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors. medRxiv

The authors thank the helpful comments of Professors Philippe Saas (Besançon, France) andMarie-Christine Béné (Nantes, France) as well as the support of Drs. Patricia Franck and Véronique Latger-Cannard from Pôle Laboratoires of CHRU-Nancy. The authors also thank the paramedical and medical team taking care of COVID-19 patients in the Surgical Intensive Care Unit of CHRU-Nancy at Brabois Hospital.